What This Lancet Review Really Says About Cannabinoids in Psychiatry
A new Lancet Psychiatry review examined 54 randomized trials of cannabinoids for mental disorders and substance use disorders, and the evidence was thinner than many public claims suggest. A few outcomes showed signals, especially in cannabis use…
Cannabis-Infused Beverages as Alcohol Alternatives: New York at Five Years
A 2026 study highlights cannabis beverage substitution alcohol as a potential alternative to traditional drinking. Adults substituting THC or CBD beverages showed measurable differences in consumption behavior. This research informs harm reduction and…
Cannabis Rescheduling Update: Advocates Eye AG Bondi Hearing for Status Report
Cannabis rescheduling update highlights potential easing of research restrictions and tax burdens. Advocates closely watch Attorney General Pam Bondi's hearing for status. This update clarifies that only Congress can legalize recreational marijuana.
